Invisible Risks in the Global Food Chain
Mycotoxins are an ongoing, invisible threat in food systems around the world. Produced by fungi such as Aspergillus, Fusarium, and Penicillium, these toxic compounds contaminate nearly 25% of the global food supply. They often remain undetected in grains, nuts, spices, and dairy products—resistant to heat and processing, and capable of causing a wide range of health effects, including liver cancer, immune suppression, and growth stunting in children.
Traditional detection methods, such as LC-MS/MS and HPLC, remain the gold standard in terms of accuracy. However, they require laboratory infrastructure, trained personnel, and hours or days to deliver results. In today’s fast-paced, international food trade environment, the need for rapid, portable, and reliable detection methods has never been greater.

Smaller Tools, Faster Results
Recent developments in biosensors, aptamer-based assays, and nanomaterial-enhanced devices are reshaping how and where mycotoxins are detected. These tools are designed to bring lab-grade detection to the point of need—whether that’s a farm gate, a shipping dock, or a food processing plant.
Immunoassays, like lateral flow strips and ELISA kits, have been widely adopted for their ease of use. They’re cost-effective, require minimal training, and can provide results within minutes. However, they can suffer from lower sensitivity and specificity, particularly when applied to complex food matrices.
Aptamer-based sensors offer a next-generation solution. Aptamers are short strands of DNA or RNA engineered to bind to specific mycotoxins with high precision. Unlike antibodies used in immunoassays, aptamers are more stable, easier to produce, and can be customized to target emerging toxins.
Biosensors integrate biological recognition elements with electronic or optical transducers. This combination allows them to convert molecular interactions into measurable signals. The result? Quick, portable detection platforms that deliver digital readouts, often in real time.

Nanomaterials: Amplifying the Signal
Nanotechnology plays a central role in improving detection sensitivity and accuracy. Materials like gold nanoparticles, carbon nanotubes, and magnetic beads are now commonly used in sensor platforms.
A standout technique is Surface-Enhanced Raman Scattering (SERS). By coating surfaces with metallic nanostructures, SERS can detect even trace levels of mycotoxins by amplifying their unique molecular signals. This method shows promise for high-sensitivity field tests, especially when paired with handheld devices.
Why This Matters Now
Global food supply chains are growing more complex, and climate change is expanding the geographical range of fungi that produce mycotoxins. Regions previously unaffected by certain toxins are now seeing increased contamination risks.
Portable biosensors and aptamer-based assays are already being tested in real-world conditions. For example, handheld mycotoxin detectors are under evaluation for use in grain silos, warehouses, and food markets across Asia and Africa. These tools can allow faster decision-making, reduce post-harvest losses, and help smallholder farmers meet export standards.

Practical Applications and Next Steps
The transition from lab to field isn’t just technical—it requires regulatory, industrial, and public health engagement. To scale up adoption:
- Regulatory bodies will need to evaluate and validate portable test kits against established standards.
- Food manufacturers can integrate these sensors at critical control points to enhance quality assurance.
- Exporters and traders may use on-site testing to prevent cross-border rejections.
- Governments and NGOs could support distribution of low-cost, easy-to-use kits in vulnerable regions.
Looking ahead, researchers are developing smart platforms that connect biosensors to cloud-based systems. This would enable real-time toxin surveillance across supply chains—from farm to table. Integration with blockchain and QR code-based labeling may also support consumer-facing transparency.
Conclusion: Toward a Safer, Smarter Food Future
Detecting mycotoxins no longer needs to be slow or inaccessible. With advances in aptamers, nanotech, and portable biosensors, food safety testing is becoming faster, smarter, and more responsive to global challenges. These tools won’t replace lab tests entirely, but they provide an essential frontline defense.
As technology continues to mature, the key challenge lies not just in innovation, but in implementation. Widespread access, affordable pricing, and public-private collaboration will determine how quickly we can close the gap between contamination and detection—and ultimately, protect global food security.

References
- Frontiers in Microbiology. (2019). Rapid immunoassays for mycotoxin detection. Frontiers
Key Takeaways
- Mycotoxin detection technology is advancing rapidly, with new platforms offering faster, more sensitive, and field-deployable testing that can reduce the time from sample to result from days to minutes.
- Lateral flow immunoassay (LFI) strips—analogous to COVID-19 rapid tests—are enabling point-of-care mycotoxin testing in grain elevators, food processing facilities, and field settings without laboratory equipment.
- Hyperspectral imaging and NIR (near-infrared) spectroscopy are being developed as non-destructive rapid screening tools that can assess grain lots for mycotoxin contamination without sampling or reagents.
- Biosensor technologies based on molecularly imprinted polymers (MIPs), aptamers, and surface plasmon resonance (SPR) are competing with immunoassay approaches for next-generation mycotoxin detection.
- The global mycotoxin testing market is projected to grow substantially over the coming decade, driven by tightening regulatory standards, expanding food safety awareness, and international trade requirements.
Frequently Asked Questions
What new technologies are changing mycotoxin detection?
Mycotoxin detection technology is undergoing rapid transformation from laboratory-based, time-consuming analytical methods toward faster, simpler, and increasingly field-deployable platforms. The technology landscape: lateral flow immunoassays (LFI, also called dipstick or strip tests): antigen-antibody based tests where a mycotoxin-containing sample flows along a membrane strip and produces a visual colour line whose intensity is inversely proportional to mycotoxin concentration; results in 5–15 minutes; quantitative readers convert colour intensity to concentration; already commercially deployed for aflatoxin, deoxynivalenol, zearalenone, and ochratoxin testing at grain receiving facilities. Lab-on-chip platforms: miniaturised analytical systems combining sample preparation, separation, and detection in a single small device; reducing sample volume, reagent consumption, and assay time while maintaining analytical performance. Aptamer-based sensors: aptamers are synthetic DNA or RNA sequences that bind specific molecules with antibody-like specificity; more stable than antibodies, cheaper to produce synthetically, and capable of detecting targets that are difficult to make antibodies against; being developed for multiple mycotoxins.
How accurate are rapid mycotoxin tests compared to laboratory methods?
Rapid mycotoxin tests (primarily lateral flow assays and related immunochemical methods) have undergone extensive validation against reference laboratory methods (primarily HPLC-MS/MS, the regulatory gold standard), with results that show good performance for screening but limitations that require understanding for appropriate use. Accuracy parameters: sensitivity (ability to detect low concentrations): modern LFI tests for aflatoxin have detection limits of approximately 1–5 μg/kg, below most regulatory action levels (EU: 4 μg/kg aflatoxin B1; US FDA: 20 μg/kg total aflatoxins), making them adequate for regulatory compliance screening. Specificity (false positive rate): immunochemical methods can produce false positives from matrix interferences or cross-reactive compounds; matrix-specific validation is important. Quantification accuracy: semi-quantitative LFI readers achieve coefficients of variation (CVs) of 10–20% in internal validations; less precise than HPLC-MS/MS (CV typically 5–10%) but adequate for regulatory screening. Regulatory status: many LFI and rapid methods have AOAC (Association of Official Analytical Chemists) method validation and are accepted for regulatory screening; positive results typically require HPLC-MS/MS confirmation before regulatory action. Practical accuracy limitation: mycotoxin distribution in grain lots is extremely heterogeneous; sampling error often exceeds analytical error in field testing—the method of sampling and sample preparation can affect results more than the analytical method choice.
Can mycotoxins be detected without laboratory testing?
Several technologies under development aim to enable mycotoxin detection without analytical chemistry—detecting contamination through physical or optical properties of the grain that correlate with mycotoxin presence. Near-infrared spectroscopy (NIRS): measures the reflected or transmitted NIR light spectrum of grain samples (seconds of measurement time, no sample preparation); correlations between NIR spectra and mycotoxin levels are established by calibrating with reference HPLC-MS/MS measurements; NIRS instruments can then predict mycotoxin content from spectra without chemical analysis. Currently deployed for moisture, protein, and oil content in grain; mycotoxin prediction is commercially available for some toxin-commodity combinations (particularly deoxynivalenol in wheat) at grain receiving terminals. Hyperspectral imaging: extends NIRS to spatial imaging—scanning a sample surface to create a mycotoxin distribution map; contaminated kernels often show subtle spectral differences detectable by hyperspectral cameras; allows sorting contaminated from clean kernels. Fluorescence: aflatoxin has a distinctive yellow-green fluorescence under UV light; fluorescence-based methods are explored as rapid screening tools. Electronic nose (e-nose): mycotoxigenic molds produce characteristic volatile compounds; e-nose instruments detect volatile profiles that correlate with mold infection and mycotoxin production.
Who needs mycotoxin testing and how often?
The universe of organisations and operators that need mycotoxin testing is broad, reflecting the distribution of mycotoxin risk through the food and feed supply chain. Grain originators (farms, co-operatives, elevators): testing at point of harvest and delivery to characterise lots and meet buyer specifications; aflatoxin and DON testing are most common at this stage; frequency varies from every load to representative samples from each field or delivery. Grain commodity traders and merchandisers: testing to verify mycotoxin compliance with destination regulatory requirements; frequency driven by origin risk (high-risk origination regions require more frequent testing) and destination requirements. Food processors: incoming commodity testing to verify mycotoxin content before blending or processing; in-process and finished product testing to verify regulatory compliance. Animal feed manufacturers: feed ingredients testing for major mycotoxins including those regulated in animal feed (aflatoxin, DON, zearalenone, fumonisins, OTA) at frequencies specified by feed safety management systems. Retail and food service buyers: increasingly requesting mycotoxin testing certification from suppliers, particularly for high-risk commodities (nuts, corn, spices). Laboratory testing frequency guidance: annual at minimum for routine commodity monitoring; more frequent for high-risk origins, following weather events that increase fungal disease risk, and for high-value products with strict regulatory requirements.
What is the future of mycotoxin testing technology?
The trajectory of mycotoxin detection technology is toward greater speed, lower cost, higher multiplexing (testing multiple toxins simultaneously), and deployment closer to the point of decision. Key developments anticipated: fully integrated field-portable instruments combining sample preparation (extraction), separation, and detection in a self-contained handheld or portable device that can be operated by non-laboratory personnel at grain receiving facilities, ports, or even in the field—several companies have prototype devices in this category. Continuous monitoring: integration of biosensor mycotoxin detection with grain storage monitoring systems that provide ongoing toxin level data rather than point-in-time measurements—alerts when conditions are producing toxin accumulation before concentrations reach regulatory limits. Multiplexed panel testing: single-sample testing for 10–30 mycotoxins simultaneously rather than single-toxin tests—already achievable by LC-MS/MS but at high cost; biosensor arrays and microfluidic platforms are working toward rapid multiplexed panels. Predictive modelling integration: combining mycotoxin measurement data with weather data, crop condition data, and machine learning models to predict mycotoxin risk before testing—supporting pre-harvest management decisions. Artificial intelligence: deep learning algorithms applied to spectral data (NIRS, hyperspectral) improving prediction accuracy beyond what traditional chemometrics achieves.